Prediction of Oncotype Dx recurrence score using clinical parameters: A comparison of available tools and a simple predictor based on grade and progesterone receptor
Objective/Background: The Oncotype Dx test is a genomic test currently used in clinical practice to predict the risk of disease recurrence in estrogen receptor (ER)-positive, HER2-negative breast cancer patients with axillary lymph node-negative or micrometastatic disease. The test is one of several...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Hematology/Oncology and Stem Cell Therapy |
| Assuntos: | |
| Acceso en liña: | https://journals.lww.com/10.1016/j.hemonc.2019.02.001 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|